Humacyte (HUMA) Change in Account Payables (2020 - 2026)
Humacyte (HUMA) reported Change in Account Payables of -$362000.0 for Q1 2026, down 155.44% year-over-year from $653000.0 in Q1 2025, and up 91.3% quarter-over-quarter from -$4.2 million in Q4 2025.
Humacyte (HUMA) Change in Account Payables (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 7 years of Change in Account Payables data on file, last reported at -$362000.0 in Q1 2026.
- Change in Account Payables for Q1 2026 came in at -$362000.0, down 155.44% year-over-year; the trailing twelve-month figure through Mar 2026 was -$42000.0 (down 102.56% YoY), and the FY2025 annual result was $973000.0, up 149.59% from the prior year.
- Change in Account Payables climbed to -$362000.0 in Q1 2026 per HUMA's latest filing, from -$4.2 million in the prior quarter.
- Over five years, Change in Account Payables peaked at $3.5 million in Q4 2023 and troughed at -$4.2 million in Q4 2025.
- A 5-year average of $173588.2 and a median of $526000.0 in 2023 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2022 and 2024: Change in Account Payables soared 5183.33% in 2022, then slumped 1086.29% in 2024.
- A 5-year view of Change in Account Payables shows it stood at -$1.5 million in 2022, then jumped by 335.7% to $3.5 million in 2023, then plunged by 169.25% to -$2.4 million in 2024, then slumped by 70.74% to -$4.2 million in 2025, then soared by 91.3% to -$362000.0 in 2026.
- Business Quant data shows HUMA's Change in Account Payables at -$362000.0 in Q1 2026, -$4.2 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -3.26 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 35.60 Mn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -9.42 Mn |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | -362,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -362,000.00 |
| Mar 31, 2026 | -362,000.00 |
| Dec 31, 2025 | -4.16 Mn |
| Dec 31, 2025 | -4.16 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Jun 30, 2025 | 1.49 Mn |
| Mar 31, 2025 | 653,000.00 |
| Mar 31, 2025 | 653,000.00 |
| Dec 31, 2024 | -2.44 Mn |
| Dec 31, 2024 | -2.44 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.31 Mn |
| Mar 31, 2024 | -2.95 Mn |
| Mar 31, 2024 | -2.95 Mn |
| Dec 31, 2023 | 3.52 Mn |
| Dec 31, 2023 | 3.52 Mn |